AAAAAA

   
Results: 1-10 |
Results: 10
Voltage and Ca2+ dye sensor approaches - Special issue on Biotechnology - Introduction
Authors: Rapundalo, ST
Citation: St. Rapundalo, Voltage and Ca2+ dye sensor approaches - Special issue on Biotechnology - Introduction, TREND CARD, 11(2), 2001, pp. 47-48
Application of proteomics to the study of cardiovascular biology
Authors: Macri, J Rapundalo, ST
Citation: J. Macri et St. Rapundalo, Application of proteomics to the study of cardiovascular biology, TREND CARD, 11(2), 2001, pp. 66-75
Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by two-dimensional electrophoresis: Surfactant effects on membrane solubilization
Authors: Macri, J McGee, B Thomas, JN Du, P Stevenson, TI Kilby, GW Rapundalo, ST
Citation: J. Macri et al., Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by two-dimensional electrophoresis: Surfactant effects on membrane solubilization, ELECTROPHOR, 21(9), 2000, pp. 1685-1693
An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company
Authors: Kohrt, JT Filipski, KJ Rapundalo, ST Cody, WL Edmunds, JJ
Citation: Jt. Kohrt et al., An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company, TETRAHEDR L, 41(32), 2000, pp. 6041-6044
Structural basis of the thrombin selectivity of a ligand that contains theconstrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl-piperidin-3-yl)-propanoic acid at P1
Authors: Narasimhan, LS Rubin, JR Holland, DR Plummer, JS Rapundalo, ST Edmunds, JE St-Denis, Y Siddiqui, MA Humblet, C
Citation: Ls. Narasimhan et al., Structural basis of the thrombin selectivity of a ligand that contains theconstrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl-piperidin-3-yl)-propanoic acid at P1, J MED CHEM, 43(3), 2000, pp. 361-368
Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors
Authors: Dudley, DA Bunker, AM Chi, LG Cody, WL Holland, DR Ignasiak, DP Janiczek-Dolphin, N McClanahan, TB Mertz, TE Narasimhan, LS Rapundalo, ST Trautschold, JA Van Huis, CA Edmunds, JJ
Citation: Da. Dudley et al., Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors, J MED CHEM, 43(22), 2000, pp. 4063-4070
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1
Authors: Cody, WL Cai, CM Doherty, AM Edmunds, JJ He, JX Narasimhan, LS Plummer, JS Rapundalo, ST Rubin, JR Van Huis, CA St-Denis, Y Winocour, PD Siddiqui, MA
Citation: Wl. Cody et al., The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1, BIOORG MED, 9(17), 1999, pp. 2497-2502
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2
Authors: Cody, WL Augelli-Szafran, CE Berryman, KA Cai, CM Doherty, AM Edmunds, JJ He, JX Narasimhan, LS Penvose-Yi, J Plummer, JS Rapundalo, ST Rubin, JR Van Huis, CA Leblond, L Winocour, PD Siddiqui, MA
Citation: Wl. Cody et al., The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2, BIOORG MED, 9(17), 1999, pp. 2503-2508
Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis
Authors: Rogers, KL Chi, L Rapundalo, ST Kramer, JB Gallagher, KP
Citation: Kl. Rogers et al., Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis, BAS R CARD, 94(1), 1999, pp. 15-22
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications
Authors: Plummer, JS Berryman, KA Cai, C Cody, WL DiMaio, J Doherty, AM Edmunds, JJ He, JX Holland, DR Levesque, S Kent, DR Narasimhan, LS Rubin, JR Rapundalo, ST Siddiqui, MA Susser, AJ St-Denis, Y Winocour, PD
Citation: Js. Plummer et al., Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications, BIOORG MED, 8(23), 1998, pp. 3409-3414
Risultati: 1-10 |